Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Asset Utilization Ratio (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.02 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 69.61% year-over-year to 0.02, compared with a TTM value of 0.02 through Dec 2025, down 69.61%, and an annual FY2025 reading of 0.0, down 96.89% over the prior year.
  • Asset Utilization Ratio was 0.02 for Q4 2025 at Abvc Biopharma, down from 0.02 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.11 in Q1 2023 and bottomed at 0.0 in Q2 2025.
  • Average Asset Utilization Ratio over 5 years is 0.04, with a median of 0.03 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio surged 1049.65% in 2023, then crashed 96.73% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.03 in 2021, then surged by 253.99% to 0.1 in 2022, then tumbled by 86.47% to 0.01 in 2023, then soared by 408.52% to 0.07 in 2024, then tumbled by 69.61% to 0.02 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ABVC at 0.02 in Q4 2025, 0.02 in Q3 2025, and 0.0 in Q2 2025.